Health advocates eye proposed changes to patent law in South Africa

South African health activists and pharmaceutical industry stakeholders are keeping close watch over the government’s attempts to amend patent laws, which activists claim compromise the ability of the country’s poor majority to access cheaper generic medicines.

Read More →

TAG and EATG applaud UNITAID agreement to reduce the cost of GeneXpert rapid TB test

Call for further price cuts on cartridges and machines to realize goals of zero TB deaths.

Read More →

Public-private partnership announces immediate 40 percent cost reduction for rapid TB test

PEPFAR, USAID, UNITAID and Bill & Melinda Gates Foundation have finalized an agreement to expand access to GeneXpert®, a molecular diagnostic system that provides a two-hour rapid diagnosis of TB, TB/HIV co-infection and drug-resistant TB.

Read More →

Tuberculosis in children

It is possible to drastically reduce the morbidity and mortality associated with pediatric tuberculosis if case detection is improved and preventive therapy and curative treatment are made more accessible globally.

Read More →

HIV and tuberculosis – science and implementation to turn the tide and reduce deaths

Progress towards reducing HIV-associated TB deaths can be achieved through attention to simple and deliverable actions on the ground.

Read More →

The co-management of TB and diabetes: challenges and opportunities in the developing world

Diabetes and TB represent a critical intersection between communicable and non-communicable diseases.

Read More →

Streptomycin regimen will no longer be used in South African province

Termination of the use of streptomycin for re-treatment cases.

Read More →

MSF: First-ever study of HIV treatment policies in 23 countries

The study looks at 25 indicators in each country, ranging from coverage of ART and prevention of mother-to-child transmission, to whether nurses instead of doctors can start patients on HIV and TB treatment.

Read More →

Trial signals major milestone in hunt for new TB drugs

Lancet paper finds novel drug regimen could be more effective than existing treatments; TB Alliance’s trial to test drugs in combination saves years in research time.

Read More →

HIV i-Base/Treatment Action Group: 2012 Pipeline Report

Recent advances in biomedical HIV, hepatitis C virus, and tuberculosis prevention and treatment are not reaching those who need them most; Political leaders continue to break domestic, global health commitments.

Read More →

Page 79 of 90 · Total posts: 10

←First 78 79 80 Last→